Back

Risk of major bleeding among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, rivaroxaban, or warfarin in the US Medicare population

28 August 2017 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 5 - Bleeding and LAA occlusion Atrial fibrillation (AF) ESC Premium Access ESC Congress 2017

About the speaker

Photo
Mr Jeffrey Trocio

New York (United States of America)

8 More presentations in this session

Presentation thumbnail
Professor R. Guo (Wuhan, CN)
Presentation thumbnail
Professor L. Fauchier (Tours, FR)
Abstract Slides
Presentation thumbnail
Professor R. Guo (Wuhan, CN)
Presentation thumbnail
Doctor V. Lekesova (Prague, CZ)
Abstract Slides
Presentation thumbnail
Miss M. Yee (Boston, US)
Abstract Slides

Access the full session

Session thumbnail
Poster session 5 - Bleeding and LAA occlusion

The Event

Event poster

ESC Congress 2017

28 August 2017 14:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources